Abattis Bioceuticals Corp. (ATTBF)

Market Cap	476.00
Revenue (ttm)	269.58K
Net Income (ttm)	-2.30M
Shares Out	476.05M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,481
Average Volume	10,197
Open	n/a
Previous Close	0.0001
Day's Range	n/a
52-Week Range	n/a
Beta	-56.88
RSI	48.15
Earnings Date	n/a

About Abattis Bioceuticals

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 201...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: ATTBF

Financial Performance

In 2019, Abattis Bioceuticals's revenue was 356,876, an increase of 4163.24% compared to the previous year's 8,371. Losses were -3.04 million, -96.10% less than in 2018.

Financial numbers in CAD